Liver fibrosis results from different etiologies and represents one of the most serious health issues worldwide. Fibrosis is the outcome of chronic insults on the liver and is associated with several factors, including abnormal iron metabolism.
Recent Advances:
Multiple mechanisms underlying the profibrogenic role of iron have been proposed. The pivotal role of liver sinusoidal endothelial cells (LSECs) in iron-level regulation, as well as their morphological and molecular dedifferentiation occurring in liver fibrosis, has encouraged research on LSECs as prime regulators of very early fibrotic events. Importantly, normal differentiated LSECs may act as gatekeepers of fibrogenesis by maintaining the quiescence of hepatic stellate cells, while LSECs capillarization precedes the onset of liver fibrosis.
Critical Issues:
In the present review, the morphological and molecular alterations occurring in LSECs after liver injury are addressed in an attempt to highlight how vascular dysfunction promotes fibrogenesis. In particular, we discuss in depth how a vicious loop can be established in which iron dysregulation and LSEC dedifferentiation synergize to exacerbate and promote the progression of liver fibrosis.
Future Directions:
LSECs, due to their pivotal role in early liver fibrosis and iron homeostasis, show great promises as a therapeutic target. In particular, new strategies can be devised for restoring LSECs differentiation and thus their role as regulators of iron homeostasis, hence preventing the progression of liver fibrosis or, even better, promoting its regression. Antioxid. Redox Signal. 35, 474–486.
Get full access to this article
View all access options for this article.
References
1.
AbeN, TsuchidaT, YasudaSI, and OkaK. Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis. Biol Open, 8: bio040519, 2019.
2.
AddoL, TanakaH, YamamotoM, TokiY, ItoS, IkutaK, SasakiK, OhtakeT, TorimotoY, FujiyaM, and KohgoY. Hepatic nerve growth factor induced by iron overload triggers defenestration in liver sinusoidal endothelial cells. Biochim Biophys Acta, 1852: 175–183, 2015.
3.
AltamuraS, SchaeperU, DamesS, LöfflerK, EisermannM, FrauendorfC, MüdderK, NevesJ, and MuckenthalerMU. SLN124, a GalNAc-siRNA conjugate targeting TMPRSS6, Efficiently prevents iron overload in hereditary haemochromatosis type 1. Hemasphere, 3: e301, 2019.
4.
AndriopoulosB, CorradiniE, XiaY, FaasseSA, ChenS, GrgurevicL, KnutsonMD, PietrangeloA, VukicevicS, LinHY, and BabittJL. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet, 41: 482–487, 2009.
5.
AsraniSK, DevarbhaviH, EatonJ, and KamathPS. Burden of liver diseases in the world. J Hepatol, 70: 151–171, 2019.
6.
AugustinHG and KohGY. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science, 357: eaal2379, 2017.
7.
BabittJL, HuangFW, WrightingDM, XiaY, SidisY, SamadTA, CampagnaJA, ChungRT, SchneyerAL, WoolfCJ, AndrewsNC, and LinHY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet, 38: 531–539, 2006.
8.
BabittJL, HuangFW, XiaY, SidisY, AndrewsNC, and LinHY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest, 117: 1933–1939, 2007.
9.
BaranovaA, LalP, BirerdincA, and YounossiZM. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol, 11: 91, 2011.
10.
BeneduceE, MatteA, De FalcoL, MbiandjeuS, ChiabrandoD, TolosanoE, FedertiE, PetrilloS, MohandasN, SicilianoA, BabuW, MenonV, GhaffariS, IolasconA, and De FranceschiL. Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. Am J Hematol, 94: 10–20, 2019.
11.
BlériotC and GinhouxF. Understanding the heterogeneity of resident liver macrophages. Front Immunol, 10: 2694, 2019.
12.
BloomerSA and BrownKE. Iron-induced liver injury: a critical reappraisal. Int J Mol Sci, 20: 2132, 2019.
13.
BraetF and WisseE. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol, 1: 1, 2002.
14.
BragdonB, MoseychukO, SaldanhaS, KingD, JulianJ, and NoheA. Bone morphogenetic proteins: a critical review. Cell Signal, 23: 609–620, 2011.
15.
BridleKR, CrawfordDH, and RammGA. Identification and characterization of the hepatic stellate cell transferrin receptor. Am J Pathol, 162: 1661–1667, 2003.
16.
ButlerJM, KobayashiH, and RafiiS. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer, 10: 138–146, 2010.
17.
CalèsP, BoursierJ, ChaigneauJ, ObertiF, and RousseletMC. Treatment of liver fibrosis: clinical aspects. Gastroenterol Clin Biol, 33: 958–966, 2009.
18.
CanaliS, WangCY, Zumbrennen-BulloughKB, BayerA, and BabittJL. Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6. Am J Hematol, 92: 1204–1213, 2017.
19.
CanaliS, Zumbrennen-BulloughKB, CoreAB, WangCY, NairzM, BouleyR, SwirskiFK, and BabittJL. Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood, 129: 405–414, 2017.
20.
CasanovasG, Mleczko-SaneckaK, AltamuraS, HentzeMW, and MuckenthalerMU. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med (Berl), 87: 471–480, 2009.
21.
ChenJ, ChloupkováM, GaoJ, Chapman-ArvedsonTL, and EnnsCA. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J Biol Chem, 282: 36862–36870, 2007.
22.
ChungJW, ShinE, KimH, HanHS, ChoJY, ChoiYR, HongS, JangES, KimJW, and JeongSH. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection. Liver Int, 38: 903–914, 2018.
CorradiniE, FerraraF, and PietrangeloA. Iron and the liver. Pediatr Endocrinol Rev 2(Suppl 2): 245–248, 2004.
25.
CrivellatoE, NicoB, and RibattiD. Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J Anat, 211: 415–427, 2007.
26.
DaherR, KannengiesserC, HouamelD, LefebvreT, Bardou-JacquetE, DucrotN, de KerguenecC, JouanolleAM, RobreauAM, OudinC, Le GacG, MoulouelB, Loustaud-RattiV, BedossaP, VallaD, GouyaL, BeaumontC, BrissotP, PuyH, KarimZ, and TchernitchkoD. Heterozygous mutations in BMP6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans. Gastroenterology, 150: 672–683.e674, 2016.
DeleveLD, WangX, and GuoY. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology, 48: 920–930, 2008.
29.
DeLeveLD, WangX, HuL, McCuskeyMK, and McCuskeyRS. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am J Physiol Gastrointest Liver Physiol, 287: G757–G763, 2004.
30.
DelgadoI, CarrascoM, CanoE, CarmonaR, García-CarboneroR, Marín-GómezLM, SoriaB, MartínF, CanoDA, Muñoz-ChápuliR, and RojasA. GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice. Hepatology, 59: 2358–2370, 2014.
31.
DétivaudL, NemethE, BoudjemaK, TurlinB, TroadecMB, LeroyerP, RopertM, JacquelinetS, CourselaudB, GanzT, BrissotP, and LoréalO. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood, 106: 746–748, 2005.
32.
Di BisceglieAM, AxiotisCA, HoofnagleJH, and BaconBR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology, 102: 2108–2113, 1992.
33.
DingBS, CaoZ, LisR, NolanDJ, GuoP, SimonsM, PenfoldME, ShidoK, RabbanySY, and RafiiS. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature, 505: 97–102, 2014.
34.
DuY, LiN, YangH, LuoC, GongY, TongC, GaoY, LüS, and LongM. Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip. Lab Chip, 17: 782–794, 2017.
35.
DuanJL, RuanB, YanXC, LiangL, SongP, YangZY, LiuY, DouKF, HanH, and WangL. Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice. Hepatology, 68: 677–690, 2018.
36.
DuarteTL, CaldasC, SantosAG, Silva-GomesS, Santos-GonçalvesA, MartinsMJ, PortoG, and LopesJM. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis. Redox Biol, 11: 157–169, 2017.
37.
DuncanAW, DorrellC, and GrompeM. Stem cells and liver regeneration. Gastroenterology, 137: 466–481, 2009.
38.
This reference has been deleted.
39.
EllisEL and MannDA. Clinical evidence for the regression of liver fibrosis. J Hepatol, 56: 1171–1180, 2012.
40.
FinbergKE, HeeneyMM, CampagnaDR, AydinokY, PearsonHA, HartmanKR, MayoMM, SamuelSM, StrouseJJ, MarkianosK, AndrewsNC, and FlemingMD. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet, 40: 569–571, 2008.
41.
FixOK and KowdleyKV. Hereditary hemochromatosis. Minerva Med, 99: 605–617, 2008.
42.
FordAJ, JainG, and RajagopalanP. Designing a fibrotic microenvironment to investigate changes in human liver sinusoidal endothelial cell function. Acta Biomater, 24: 220–227, 2015.
43.
GanzT.Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 102: 783–788, 2003.
44.
GaoJ, ChenJ, KramerM, TsukamotoH, ZhangAS, and EnnsCA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab, 9: 217–227, 2009.
45.
GeorgeDK, GoldwurmS, MacDonaldGA, CowleyLL, WalkerNI, WardPJ, JazwinskaEC, and PowellLW. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 114: 311–318, 1998.
GéraudC, SchledzewskiK, DemoryA, KleinD, KausM, PeyreF, StichtC, EvdokimovK, LuS, SchmiederA, and GoerdtS. Liver sinusoidal endothelium: a microenvironment-dependent differentiation program in rat including the novel junctional protein liver endothelial differentiation-associated protein-1. Hepatology, 52: 313–326, 2010.
48.
GoveiaJ, StaporP, and CarmelietP. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med, 6: 1105–1120, 2014.
49.
Gracia-SanchoJ, LaviñaB, Rodríguez-VilarruplaA, García-CalderóH, BoschJ, and García-PagánJC. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. J Hepatol, 47: 220–227, 2007.
50.
GreuterT and ShahVH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol, 51: 511–519, 2016.
51.
GruysE, ToussaintMJ, NiewoldTA, and KoopmansSJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B, 6: 1045–1056, 2005.
52.
This reference has been deleted.
53.
This reference has been deleted.
54.
HammouteneA and RautouPE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol, 70: 1278–1291, 2019.
55.
HasebeT, TanakaH, SawadaK, NakajimaS, OhtakeT, FujiyaM, and KohgoY. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. J Gastroenterol, 52: 341–351, 2017.
56.
HentzeMW, MuckenthalerMU, GalyB, and CamaschellaC. Two to tango: regulation of mammalian iron metabolism. Cell, 142: 24–38, 2010.
57.
HwaAJ, FryRC, SivaramanA, SoPT, SamsonLD, StolzDB, and GriffithLG. Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J, 21: 2564–2579, 2007.
58.
IkomaN, ShinozakiH, KozukiA, IbukiS, SuganoK, MukaiM, MasudaY, KobayashiK, and OgataY. A case report of hepatocellular carcinoma in a non-cirrhotic patient with liver iron overload associated with myelodysplastic syndrome. World J Oncol, 4: 248–251, 2013.
59.
IsaacsMJ, KawakamiY, AllendorphGP, YoonBH, Izpisua BelmonteJC, and ChoeS. Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly. Mol Endocrinol, 24: 1469–1477, 2010.
60.
KatsarouMS, PapasavvaM, LatsiR, and DrakoulisN. Hemochromatosis: hereditary hemochromatosis and HFE gene. Vitam Horm, 110: 201–222, 2019.
61.
KmiećZ.Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161: III–XIII, 1–151, 2001.
62.
KnorrA, Hirth-DietrichC, Alonso-AlijaC, HärterM, HahnM, KeimY, WunderF, and StaschJP. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60–2770 in experimental liver fibrosis. Arzneimittelforschung, 58: 71–80, 2008.
63.
KoC, SiddaiahN, BergerJ, GishR, BrandhagenD, SterlingRK, CotlerSJ, FontanaRJ, McCashlandTM, HanSH, GordonFD, SchilskyML, and KowdleyKV. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int, 27: 1394–1401, 2007.
64.
KochPS, OlsavszkyV, UlbrichF, StichtC, DemoryA, LeibingT, HenzlerT, MeyerM, ZierowJ, SchneiderS, Breitkopf-HeinleinK, GaitantziH, Spencer-DeneB, ArnoldB, KlapprothK, SchledzewskiK, GoerdtS, and GéraudC. Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood, 129: 415–419, 2017.
65.
KovacS, BöserP, CuiY, Ferring-AppelD, CasarrubeaD, HuangL, FungE, PoppA, MuellerBK, and HentzeMW. Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels. Haematologica, 101: e173–e176, 2016.
66.
KowdleyKV.Iron overload in patients with chronic liver disease. Gastroenterol Hepatol (N Y), 12: 695–698, 2016.
67.
KowdleyKV, BrandhagenDJ, GishRG, BassNM, WeinsteinJ, SchilskyML, FontanaRJ, McCashlandT, CotlerSJ, BaconBR, KeeffeEB, GordonF, PolissarN, and RegistryNHT. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology, 129: 494–503, 2005.
68.
LammertE, CleaverO, and MeltonD. Induction of pancreatic differentiation by signals from blood vessels. Science, 294: 564–567, 2001.
69.
LatourC, Besson-FournierC, GourbeyreO, MeynardD, RothMP, and CoppinH. Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge. Blood, 130: 2339–2343, 2017.
70.
LatourC, Besson-FournierC, MeynardD, SilvestriL, GourbeyreO, Aguilar-MartinezP, SchmidtPJ, FlemingMD, RothMP, and CoppinH. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology, 63: 126–137, 2016.
71.
LeachHG, ChrobakI, HanR, and TrojanowskaM. Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury. Am J Respir Cell Mol Biol, 49: 1093–1101, 2013.
72.
LeeSH, JeongSH, ParkYS, HwangJH, KimJW, KimN, and LeeDH. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease. Korean J Hepatol, 16: 288–294, 2010.
73.
LimPJ, DuarteTL, ArezesJ, Garcia-SantosD, HamdiA, PasrichaSR, ArmitageAE, MehtaH, WidemanS, SantosAG, Santos-GonçalvesA, MorovatA, HughesJR, SoilleuxE, WangCY, BayerAL, KlenermanP, WillbergCB, HartleyRC, MurphyMP, BabittJL, PonkaP, PortoG, and DrakesmithH. Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin. Nat Metab, 1: 519–531, 2019.
74.
LinL, ValoreEV, NemethE, GoodnoughJB, GabayanV, and GanzT. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood, 110: 2182–2189, 2007.
75.
MarchS, HuiEE, UnderhillGH, KhetaniS, and BhatiaSN. Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology, 50: 920–928, 2009.
Martinez-HernandezA and MartinezJ. The role of capillarization in hepatic failure: studies in carbon tetrachloride-induced cirrhosis. Hepatology, 14: 864–874, 1991.
78.
MassaguéJ and GomisRR. The logic of TGFbeta signaling. FEBS Lett, 580: 2811–2820, 2006.
MatsumotoK, YoshitomiH, RossantJ, and ZaretKS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science, 294: 559–563, 2001.
81.
MayD, DjonovV, ZamirG, BalaM, SafadiR, Sklair-LevyM, and KeshetE. A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations. PLoS One, 6: e21478, 2011.
82.
McGuireRF, BissellDM, BoylesJ, and RollFJ. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology, 15: 989–997, 1992.
83.
McMahanRH, PorscheCE, EdwardsMG, and RosenHR. Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: insights into non-alcoholic fatty liver disease. PLoS One, 11: e0159217, 2016.
84.
MehtaKJ, CoombesJD, Briones-OrtaM, MankaPP, WilliamsR, PatelVB, and SynWK. Iron enhances hepatic fibrogenesis and activates transforming growth factor-β signaling in murine hepatic stellate cells. Am J Med Sci, 355: 183–190, 2018.
85.
MehtaKJ, FarnaudSJ, and SharpPA. Iron and liver fibrosis: mechanistic and clinical aspects. World J Gastroenterol, 25: 521–538, 2019.
86.
MiletJ, Le GacG, ScotetV, GourlaouenI, ThèzeC, MosserJ, BourgainC, DeugnierY, and FérecC. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study. Blood Cells Mol Dis, 44: 34–37, 2010.
87.
MiyaoM, KotaniH, IshidaT, KawaiC, ManabeS, AbiruH, and TamakiK. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest, 95: 1130–1144, 2015.
88.
MiyaoM, OzekiM, AbiruH, ManabeS, KotaniH, TsuruyamaT, and TamakiK. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis. Dig Liver Dis, 45: 216–225, 2013.
89.
MuckenthalerMU, RivellaS, HentzeMW, and GalyB. A red carpet for iron metabolism. Cell, 168: 344–361, 2017.
90.
NaiA, RubioA, CampanellaA, GourbeyreO, ArtusoI, BordiniJ, GinesteA, LatourC, Besson-FournierC, LinHY, CoppinH, RothMP, CamaschellaC, SilvestriL, and MeynardD. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood, 127: 2327–2336, 2016.
91.
NatarajanV, HarrisEN, and KidambiS. SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis. Biomed Res Int, 2017: 4097205, 2017.
92.
NemethE, TuttleMS, PowelsonJ, VaughnMB, DonovanA, WardDM, GanzT, and KaplanJ. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306: 2090–2093, 2004.
93.
NiY, LiJM, LiuMK, ZhangTT, WangDP, ZhouWH, HuLZ, and LvWL. Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol, 23: 7666–7677, 2017.
94.
NicolasG, ViatteL, BennounM, BeaumontC, KahnA, and VaulontS. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis, 29: 327–335, 2002.
95.
NolanDJ, GinsbergM, IsraelyE, PalikuqiB, PoulosMG, JamesD, DingBS, SchachterleW, LiuY, RosenwaksZ, ButlerJM, XiangJ, RafiiA, ShidoK, RabbanySY, ElementoO, and RafiiS. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell, 26: 204–219, 2013.
96.
OgawaK, MinaseT, EnomotoK, and OnoéT. Ultrastructure of fenestrated cells in the sinusoidal wall of rat liver after perfusion fixation. Tohoku J Exp Med, 110: 89–101, 1973.
97.
OlsavszkyV, UlbrichF, SinghS, DiettM, StichtC, SchmidCD, ZierowJ, WohlfeilSA, SchledzewskiK, DooleyS, GaitantziH, Breitkopf-HeinleinK, GéraudC, GoerdtS, and KochPS. GATA4 and LMO3 balance angiocrine signaling and autocrine inflammatory activation by BMP2 in liver sinusoidal endothelial cells. Gene, 627: 491–499, 2017.
98.
ParkCH, ValoreEV, WaringAJ, and GanzT. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem, 276: 7806–7810, 2001.
99.
ParrowNL and FlemingRE. Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr, 34: 77–94, 2014.
100.
ParrowNL and FlemingRE. Liver sinusoidal endothelial cells as iron sensors. Blood, 129: 397–398, 2017.
101.
PatelN, MasaratanaP, Diaz-CastroJ, Latunde-DadaGO, QureshiA, LockyerP, JacobM, ArnoM, MatakP, MitryRR, HughesRD, DhawanA, PattersonC, SimpsonRJ, and McKieAT. BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice. J Biol Chem, 287: 4099–4106, 2012.
PigeonC, IlyinG, CourselaudB, LeroyerP, TurlinB, BrissotP, and LoréalO. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem, 276: 7811–7819, 2001.
104.
PoissonJ, LemoinneS, BoulangerC, DurandF, MoreauR, VallaD, and RautouPE. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol, 66: 212–227, 2017.
105.
RammGA, BrittonRS, O'NeillR, and BaconBR. Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes. J Clin Invest, 94: 9–15, 1994.
106.
RammGA and RuddellRG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis, 25: 433–449, 2005.
107.
RausaM, PaganiA, NaiA, CampanellaA, GilbertiME, ApostoliP, CamaschellaC, and SilvestriL. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?. PLoS One, 10: e0122696, 2015.
108.
RockeyDC and ChungJJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology, 114: 344–351, 1998.
109.
RuartM, ChavarriaL, CampreciósG, Suárez-HerreraN, MontironiC, Guixé-MuntetS, BoschJ, FriedmanSL, Garcia-PagánJC, and Hernández-GeaV. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol, 70: 458–469, 2019.
110.
SchaffnerF and PoperH. Capillarization of hepatic sinusoids in man. Gastroenterology, 44: 239–242, 1963.
111.
SchmidCD, SchledzewskiK, MoglerC, WaldburgerN, KalnaV, MarxA, RandiAM, GéraudC, GoerdtS, and KochPS. GPR182 is a novel marker for sinusoidal endothelial differentiation with distinct GPCR signaling activity in vitro. Biochem Biophys Res Commun, 497: 32–38, 2018.
112.
SibilleJC, KondoH, and AisenP. Interactions between isolated hepatocytes and Kupffer cells in iron metabolism: a possible role for ferritin as an iron carrier protein. Hepatology, 8: 296–301, 1988.
113.
SørensenKK, McCourtP, BergT, CrossleyC, Le CouteurD, WakeK, and SmedsrødB. The scavenger endothelial cell: a new player in homeostasis and immunity. Am J Physiol Regul Integr Comp Physiol, 303: R1217–R1230, 2012.
114.
TackeF and TrautweinC. Mechanisms of liver fibrosis resolution. J Hepatol, 63: 1038–1039, 2015.
115.
TolosanoE, FagooneeS, MorelloN, VinchiF, and FioritoV. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal, 12: 305–320, 2010.
116.
TortiFM and TortiSV. Regulation of ferritin genes and protein. Blood, 99: 3505–3516, 2002.
117.
TsochatzisE, PapatheodoridisGV, KoliarakiV, HadziyannisE, KafiriG, ManesisEK, MamalakiA, and ArchimandritisAJ. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat, 17: 800–806, 2010.
118.
TuguesS, Morales-RuizM, Fernandez-VaroG, RosJ, ArtetaD, Muñoz-LuqueJ, ArroyoV, RodésJ, and JiménezW. Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats. Gastroenterology, 129: 1686–1695, 2005.
119.
WangRH, LiC, XuX, ZhengY, XiaoC, ZerfasP, CoopermanS, EckhausM, RouaultT, MishraL, and DengCX. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab, 2: 399–409, 2005.
120.
WeissA and AttisanoL. The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol, 2: 47–63, 2013.
121.
WidmannJJ and FahimiHD. Proliferation of mononuclear phagocytes (Kupffer cells) and endothelial cells in regenerating rat liver. A light and electron microscopic cytochemical study. Am J Pathol, 80: 349–366, 1975.
122.
WisseE.An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res, 31: 125–150, 1970.
123.
WisseE.An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells. J Ultrastruct Res, 38: 528–562, 1972.
124.
WisseE, De ZangerRB, JacobsR, and McCuskeyRS. Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc Pt 3: 1441–1452, 1983.
125.
XiaoX, DevS, CanaliS, BayerA, XuY, AgarwalA, WangCY, and BabittJL.Endothelial Bmp2 knockout exacerbates hemochromatosis in Hfe knockout mice but not Bmp6 knockout mice. Hepatology 2019. [Epub ahead of print]; DOI: 10.1002/hep.31048.
126.
XieG, WangL, WangX, and DeLeveLD. Isolation of periportal, midlobular, and centrilobular rat liver sinusoidal endothelial cells enables study of zonated drug toxicity. Am J Physiol Gastrointest Liver Physiol, 299: G1204–G1210, 2010.
127.
XieG, WangX, WangL, AtkinsonRD, KanelGC, GaardeWA, and DeleveLD. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology, 142: 918–927.e916, 2012.
128.
XuB, BroomeU, UzunelM, NavaS, GeX, Kumagai-BraeschM, HultenbyK, ChristenssonB, EriczonBG, HolgerssonJ, and Sumitran-HolgerssonS. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am J Pathol, 163: 1275–1289, 2003.
129.
XuM, WangX, ZouY, and ZhongY. Key role of liver sinusoidal endothelial cells in liver fibrosis. Biosci Trends, 11: 163–168, 2017.
130.
ZhangAS, AndersonSA, WangJ, YangF, DeMasterK, AhmedR, NizziCP, EisensteinRS, TsukamotoH, and EnnsCA. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood, 117: 1687–1699, 2011.
131.
ZhangF, ZhangZ, ChenL, KongD, ZhangX, LuC, LuY, and ZhengS. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med, 18: 1392–1406, 2014.
